Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer

QR Code

Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer

None

Saved in:

Bibliographic Details
Main Authors:	Ina, Kenji, Furuta, Ryuichi, Kataoka, Takae, Kayukawa, Satoshi, Iwase, Hiroaki
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/16467
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery
by: Siqi Wu, et al.
Published: (2025-06-01)

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule
by: M. B. Sokol, et al.
Published: (2021-11-01)

COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
by: A. V. Shabunin, et al.
Published: (2018-07-01)

UNCONVENTIONAL FRACTIONATION RADIOTHERAPY REGIMENS IN TREATMENT OF INOPERABLE LUNG CANCER
by: D. V. Gogolin, et al.
Published: (2019-09-01)

Stereotactic body radiation therapy for inoperable localized kidney cancer
by: Zh. E. Sabelnikova, et al.
Published: (2023-05-01)

Modern and minimally invasive formulations with paclitaxel
by: Andreea Crețeanu, et al.
Published: (2025-01-01)

Cisplatin, the Timeless Molecule
by: Annaluisa Mariconda, et al.
Published: (2025-07-01)

ACCELERATED HYPERFRACTIONATED RADIOTHERAPY IN THE TREATMENT FOR INOPERABLE, LOCALLY ADVANCED GASTRIC CANSER
by: S. S. Litinskiy, et al.
Published: (2016-02-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
by: N. V. Marukyan, et al.
Published: (2021-05-01)

SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES
by: Z. H. Dadacheva, et al.
Published: (2014-12-01)

Transcatheter Aortic Valve Implantation: New Hope for Inoperable and High-Risk Patients
by: Hayashida, Kentaro, et al.
Published: (2011)

Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
by: Yimin Lu, et al.
Published: (2017-04-01)

“Nano-Paclitaxel” Unlocking Potential and Redefining Cancer Chemotherapy
by: Anuja Muley, et al.
Published: (2025-06-01)

Comparative acute toxicity of intravenous paclitaxel and sirolimus in rats
by: Jing Xie, et al.
Published: (2025-01-01)

Time and the hour /
by: Spring, Howard
Published: (1964)

Black hours /
by: King, Wayne, 1948-
Published: (1996)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023-08-01)

Cisplatin Resistance in Malignant Pleural Mesothelioma
by: Behnam-Motlagh, Parviz, et al.
Published: (2012)

EFFECT OF CISPLATIN ON HEMOSTASIS IN EXPERIMENTAL ANIMALS
by: M. V. Filonova, et al.
Published: (2020-07-01)

ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH INOPERABLE LUNG CANCER DURING RADIOTHERAPY AND PHOTODYNAMIC THERAPY
by: Yu. A. Ragulin, et al.
Published: (2020-01-01)

Cost-effectiveness study of the MitraClip system for mitral regurgitation treatment in inoperable patients
by: E. G. Fedina, et al.
Published: (2021-09-01)

A case of Frégoli syndrome following 24-hour levodopa-carbidopa intestinal gel infusion in a patient with Parkinson’s disease undergoing STN-DBS
by: Shunsuke Ogata, et al.
Published: (2025-01-01)

Midkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung Cancer
by: Shotaro Ito, et al.
Published: (2025-07-01)

Poly (L-glutamic acid)-Paclitaxel Conjugates for Cancer Treatment
by: Zhang, Shuang-Qing
Published: (2012)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Triple stem cell infusion alleviated graft-versus-host disease and improves outcomes in unmanipulated haploidentical hematopoietic stem cell transplantation
by: Fang Hua, et al.
Published: (2025-07-01)

CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease
by: Ivana Raffaele, et al.
Published: (2025-06-01)

Psychiatric Implications of Genetic Variations in Oligodendrocytes: Insights from hiPSC Models
by: Martina D’Angelo, et al.
Published: (2025-06-01)

Single cell proteomics reveals proteome heterogeneity in iPSC-derived cardiomyocytes
by: Lizhuo Ai, et al.
Published: (2025-06-01)

Neonatal Infusion Therapy
by: Ye. A. Zhukov, et al.
Published: (2008-08-01)

Target-Controlled Infusion
by: V. Holly, et al.
Published: (2009-04-01)

The hour of our death
by: Aries, Philippe
Published: (1981)

Twenty-four hours /
by: Bromfield, Louis
Published: (1959)

Furniture in 24 hours /
by: Zakas, Spiros
Published: (1976)

One million hours.

Working hours : assessing the potential for reduction /
by: White, Michael
Published: (1987)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)